Oorsprong van het eerstegraads netwerk van Charles Askew
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Nabgen, Inc.
1
| Private Company | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Charles Askew via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
GeneVentiv Therapeutics, Inc.
 GeneVentiv Therapeutics, Inc. BiotechnologyHealth Technology GeneVentiv Therapeutics, Inc. is a company that is developing the first gene therapy for patients with hemophilia A or B, with or without inhibitors. The company is based in Raleigh, NC. The company's product, Genv-Hem, produces clotting factor Va, which allows for normal clotting in response to injury. Currently, there are no curative gene therapies available for patients with inhibitors. GeneVentiv Therapeutics was founded by Chengwen Li and the CEO is Damon R Race. | Biotechnology | Founder |
Statistieken
Internationaal
| Verenigde Staten | 2 |
Sectoraal
| Health Technology | 2 |
Operationeel
| Founder | 1 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Chengwen Li | 2 |
- Beurs
- Insiders
- Charles Askew
- Bedrijfsconnecties
